Genome-wide association study identifies three novel genetic markers associated with elite endurance performance

Ii Ahmetov, Na Kulemin, Dv Popov, Va Naumov, Eb Akimov, Yr Bravy, Es Egorova, Aa Galeeva, Ev Generozov, Es Kostryukova, Ak Larin, Lj Mustafina, Ea Ospanova, Av Pavlenko, Lm Starnes, P Żmijewski, Dg Alexeev, Ol Vinogradova, Vm Govorun, Ii Ahmetov, Na Kulemin, Dv Popov, Va Naumov, Eb Akimov, Yr Bravy, Es Egorova, Aa Galeeva, Ev Generozov, Es Kostryukova, Ak Larin, Lj Mustafina, Ea Ospanova, Av Pavlenko, Lm Starnes, P Żmijewski, Dg Alexeev, Ol Vinogradova, Vm Govorun

Abstract

To investigate the association between multiple single-nucleotide polymorphisms (SNPs), aerobic performance and elite endurance athlete status in Russians. By using GWAS approach, we examined the association between 1,140,419 SNPs and relative maximal oxygen consumption rate ([Formula: see text]O2max) in 80 international-level Russian endurance athletes (46 males and 34 females). To validate obtained results, we further performed case-control studies by comparing the frequencies of the most significant SNPs (with P < 10(-5)-10(-8)) between 218 endurance athletes and opposite cohorts (192 Russian controls, 1367 European controls, and 230 Russian power athletes). Initially, six 'endurance alleles' were identified showing discrete associations with [Formula: see text]O2max both in males and females. Next, case-control studies resulted in remaining three SNPs (NFIA-AS2 rs1572312, TSHR rs7144481, RBFOX1 rs7191721) associated with endurance athlete status. The C allele of the most significant SNP, rs1572312, was associated with high values of [Formula: see text]O2max (males: P = 0.0051; females: P = 0.0005). Furthermore, the frequency of the rs1572312 C allele was significantly higher in elite endurance athletes (95.5%) in comparison with non-elite endurance athletes (89.8%, P = 0.0257), Russian (88.8%, P = 0.007) and European (90.6%, P = 0.0197) controls and power athletes (86.2%, P = 0.0005). The rs1572312 SNP is located on the nuclear factor I A antisense RNA 2 (NFIA-AS2) gene which is supposed to regulate the expression of the NFIA gene (encodes transcription factor involved in activation of erythropoiesis and repression of the granulopoiesis). Our data show that the NFIA-AS2 rs1572312, TSHR rs7144481 and RBFOX1 rs7191721 polymorphisms are associated with aerobic performance and elite endurance athlete status.

Keywords: GWAS; VO2max; athletes; endurance; genotype; polymorphism.

References

    1. Bouchard C, Sarzynski MA, Rice TK, Kraus WE, Church TS, Sung YJ, Rao DC, Rankinen T. Genomic predictors of the maximal O2 uptake response to standardized exercise training programs. J Appl Physiol. 2011;110(5):1160–70.
    1. Timmons JA, Knudsen S, Rankinen T, Koch LG, Sarzynski M, Jensen T, Keller P, Scheele C, Vollaard NBJ, Nielsen S, Akerström T, MacDougald OA, Jansson E, Greenhaff PL, Tarnopolsky MA, van Loon LJC, Pedersen BK, Sundberg CJ, Wahlestedt C, Britton SL, Bouchard C. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol. 2010;108(6):1487–96.
    1. Brzeziańska E, Domańska D, Jegier A. Gene doping in sport – perspectives and risks. Biol Sport. 2014;31(4):251–9.
    1. Pokrywka A, Kaliszewski P, Majorczyk E, Zembroń-Łacny A. Genes in sport and doping. Biol Sport. 2013;30(3):155–61.
    1. Bray MS, Hagberg JM, Pérusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc. 2009;41(1):35–73.
    1. Wang G, Padmanabhan S, Wolfarth B, Fuku N, Lucia A, Ahmetov II, Cieszczyk P, Collins M, Eynon N, Klissouras V, Williams A, Pitsiladis Y. Genomics of elite sporting performance: what little we know and necessary advances. Adv Genet. 2013;84:123–49.
    1. Ahmetov II, Khakimullina AM, Popov DV, Missina SS, Vinogradova OL, Rogozkin VA. Polymorphism of the vascular endothelial growth factor gene (VEGF) and aerobic performance in athletes. Hum Physiol. 2008;34(4):477–81.
    1. Ahmetov II, Hakimullina AM, Popov DV, Lyubaeva EV, Missina SS, Vinogradova OL, Williams AG, Rogozkin VA. Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes. Eur J Appl Physiol. 2009;107(1):95–103.
    1. Cieszczyk P, Krupecki K, Maciejewska A, Sawczuk M. The angiotensin converting enzyme gene I/D polymorphism in Polish rowers. Int J Sports Med. 2009;30(8):624–7.
    1. Döring F, Onur S, Fischer A, Boulay MR, Pérusse L, Rankinen T, Rauramaa R, Wolfarth B, Bouchard C. A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1alpha (HIF1A) gene in elite endurance athletes. J Appl Physiol. 2010;108(6):1497–500.
    1. Maciejewska A, Sawczuk M, Cieszczyk P, Mozhayskaya IA, Ahmetov II. The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci. 2012;30(1):101–13.
    1. Wang G, Mikami E, Chiu L-L, DE Perini A, Deason M, Fuku N, Miyachi M, Kaneoka K, Murakami H, Tanaka M, Hsieh L-L, Hsieh SS, Caporossi D, Pigozzi F, Hilley A, Lee R, Galloway SDR, Gulbin J, Rogozkin VA, Ahmetov II, Yang N, North KN, Ploutarhos S, Montgomery HE, Bailey MES, Pitsiladis YP. Association analysis of ACE and ACTN3 in elite Caucasian and East Asian swimmers. Med Sci Sports Exerc. 2013;45(5):892–900.
    1. Drozdovska SB, Dosenko VE, Ahmetov II, Ilyin VN. The association of gene polymorphisms with athlete status in Ukrainians. Biol Sport. 2013;30(3):163–7.
    1. Eynon N, Ruiz JR, Bishop DJ, Santiago C, Gómez-Gallego F, Lucia A, Birk R. The rs12594956 polymorphism in the NRF-2 gene is associated with top-level Spanish athlete's performance status. J Sci Med Sport. 2013;16(2):135–9.
    1. Akhmetov II, Popov DV, Mozhaĭskaia IA, Missina SS, Astratenkova IV, Vinogradova OL, Rogozkin VA. Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes. Ross Fiziol Zh Im I M Sechenova. 2007;93(8):837–43.
    1. Akhmetov II, Linde EV, Shikhova IV, Popov DV, Missina SS, Vinogradoba OL, Rogozkin VA. The influence of calcineurin gene polymorphism on morphofunctional characteristics of cardiovascular system of athletes. Ross Fiziol Zh Im I M Sechenova. 2008;94(8):915–22.
    1. Fedotovskaya ON, Popov DV, Vinogradova OL, Akhmetov II. Association of muscle-specific creatine kinase (CKMM) gene polymorphism with physical performance of athletes. Hum Physiol. 2012;38(1):89–93.
    1. Fedotovskaya ON, Mustafina LJ, Popov DV, Vinogradova OL, Ahmetov II. A common polymorphism of the MCT1 gene and athletic performance. Int J Sports Physiol Perform. 2014;9(1):173–80.
    1. Lucia A, Gómez-Gallego F, Barroso I, Rabadán M, Bandrés F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ, Franks PW. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol. 2005;99(1):344–8.
    1. Mustafina LJ, Naumov VA, Cieszczyk P, Popov DV, Lyubaeva EV, Kostryukova ES, Fedotovskaya ON, Druzhevskaya AM, Astratenkova IV, Glotov AS, Alexeev DG, Mustafina MM, Egorova ES, Maciejewska- Karlowska A, Larin AK, Generozov EV, Nurullin RE, Jastrzębski Z, Kulemin NA, Ospanova EA, Pavlenko AV, Sawczuk M, Akimov EB, Danilushkina AA, Zmijewski P, Vinogradova OL, Govorun VM, Ahmetov II. AGTR2 gene polymorphism is associated with muscle fibre composition, athletic status and aerobic performance. Exp Physiol. 2014;99(8):1042–52.
    1. Stranger BE, Stahl EA, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics. 2011;187(2):367–83.
    1. Hughes DC, Day SH, Ahmetov II, Williams AG. Genetics of muscle strength and power: polygenic profile similarity limits skeletal muscle performance. J Sports Sci. 2011;29(13):1425–34.
    1. Liu X-G, Tan L-J, Lei S-F, Liu Y-J, Shen H, Wang L, Yan H, Guo Y-F, Xiong D-H, Chen X-D, Pan F, Yang T-L, Zhang Y-P, Guo Y, Tang NL, Zhu X-Z, Deng H-Y, Levy S, Recker RR, Papasian CJ, Deng H-W. Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. Am J Hum Genet. 2009;84(3):418–23.
    1. Liu F, Hendriks AEJ, Ralf A, Boot AM, Benyi E, Sävendahl L, Oostra BA, van Duijn C, Hofman A, Rivadeneira F, Uitterlinden AG, Drop SLS, Kayser M. Common DNA variants predict tall stature in Europeans. Hum Genet. 2014;133(5):587–97.
    1. Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847–65.
    1. Kallen AN, Zhou X-B, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi J-S, Zhang H, Min W, Bennett AM, Gregory RI, Ding Y, Huang Y. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52(1):101–12.
    1. Starnes LM, Sorrentino A, Pelosi E, Ballarino M, Morsilli O, Biffoni M, Santoro S, Felli N, Castelli G, De Marchis ML, Mastroberardino G, Gabbianelli M, Fatica A, Bozzoni I, Nervi C, Peschle C. NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression. Blood. 2009;114(9):1753–63.
    1. Theobald J, DiMario JX. Lineage-based primary muscle fiber type diversification independent of MEF2 and NFAT in chick embryos. J Muscle Res Cell Motil. 2011;31(5-6):369–81.
    1. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, Williams RS. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J. 2001;20(22):6414–23.
    1. Simonides WS, van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid. 2008;18(2):205–16.
    1. Balzan S, Del Carratore R, Nicolini G, Beffy P, Lubrano V, Forini F, Iervasi G. Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor. J Clin Endocrinol Metab. 2012;97(5):1763–70.
    1. Kuroyanagi H. Fox-1 family of RNA-binding proteins. Cell Mol Life Sci. 2009;66(24):3895–907.
    1. Fogel BL, Wexler E, Wahnich A, Friedrich T, Vijayendran C, Gao F, Parikshak N, Konopka G, Geschwind DH. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum Mol Genet. 2012;21(19):4171–86.
    1. Sengupta N, Yau C, Sakthianandeswaren A, Mouradov D, Gibbs P, Suraweera N, Cazier J-B, Polanco-Echeverry G, Ghosh A, Thaha M, Ahmed S, Feakins R, Propper D, Dorudi S, Sieber O, Silver A, Lai C. Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion. Mol Cancer. 2013;12:1.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren